Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    11568561 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Prevacid vs Lifestyle Modifications for the Treatment of LPR
Condition: Laryngopharyngeal Reflux
Interventions: Drug: Prevacid 30mg BID;   Behavioral: Lifestyle changes of exercise and diet changes for weight loss and avoidance of reflux inducing foods.
2 Withdrawn Laryngomalacia Study
Condition: Laryngomalacia
Interventions: Drug: Omeprazole;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.